QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
City of Industry, CA -- (SBWIRE) -- 09/11/2018 -- This report focuses on the global GMP Cell Banking Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the GMP Cell Banking Services development in United States, Europe and China.
The creation of a regulatory-compliant cell bank is an essential component in the production of well characterised biopharmaceutical products. The use of qualified cell banks provides opportunity to detect and identify (and thereby exclude) possible contaminating adventitious agents such as viruses and mycoplasma prior to their use in manufacture.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/702916/global-gmp-cell-banking-services-market
Global biopharmaceutical companies are making a more significant commitment to outsourcing by striving to improve operating efficiency and increase pipeline productivity. Biotechnology companies and other private organizations have always preferred outsourcing to investing in internal infrastructure. Academic institutions are also partnering with biopharmaceutical companies to monetize innovation and acquire expertise in drug discovery and development.
The mammalian cell type segment dominated the United States GMP cell banking services market in revenue terms in 2017 and is projected to continue to do so throughout the forecast period. The mammalian cell type segment is the most attractive segment in the United States regional market, recording an attractiveness index of 5.1 over the forecast period.
APAC is likely to witness relatively fast growth among other regions over the coming years. Whereas, due to shift in investments related to technology and research and development in the healthcare industry from United States and Europe to Asia Pacific is likely to impact growth of the market positively in the coming years.
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/c9235012c3adcc384f2d0aa15dad3741,0,1,Global%20GMP%20Cell%20Banking%20Services%20Market%20Size%252C%20Status%20and%20Forecast%202018-2025
The key players covered in this study
WuXi AppTec
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Lonza
SGS Ltd
ViruSure
Austrianova
Goodwin Biotechnology
Paragon Bioservices
BioReliance
Sartorious
BSL Bioservice
Cleancells
Charles River Laboratories
Covance
Market segment by Type, the product can be split into
Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others
Market segment by Application, split into
Biopharmaceutical Companies
Contract Manufacturing Organizations
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/702916/global-gmp-cell-banking-services-market
About QYResearch
QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.